Table 1. Baseline demographic and clinical characteristics.
AON cohort | MS Control Cohort* | P-value | |
---|---|---|---|
| |||
Patients (eyes) | 33 (65) | 33 (66) | - |
| |||
Age, y, mean (SD) | 36.3 (9.5) | 35.9 (9.1) | 0.85a |
| |||
Female, n (%) | 29 (88) | 29 (88) | 1.00b |
| |||
Race, n (%) ‡ | 0.31b | ||
White | 22 (67) | 28 (85) | |
Black | 7 (21) | 4 (12) | |
Hispanic | 2 (6) | 0 (0) | |
Other | 2 (6) | 1 (3) | |
| |||
Disease duration, years, median (IQR) | 1.25 (0.5-8) | 7 (3-11) | 0.009c |
| |||
Eyes with a previous history of AON, n (%) | 12 (18.2) | 19 (28.8) | 0.15d |
| |||
Follow-up duration, months, median (IQR) | 22.8 (12.6-34.2) | 23.6 (14.2-36.1) | 0.68c |
Abbreviations: AON = Acute optic neuritis; MS = multiple sclerosis; SD = standard deviation; CIS = clinically isolated syndrome; RRMS = relapsing-remitting multiple sclerosis; IQR = interquartile range.
No patients in this cohort had AON at study entry or developed AON during follow-up.
Race was self-reported.
Two-sample Student's t-test.
Fisher's exact test.
Mann–Whitney U test.
Chi-squared test.